Skip to main content
. Author manuscript; available in PMC: 2022 Jan 22.
Published in final edited form as: Gastroenterology. 2021 Feb 19;160(7):2317–2327.e2. doi: 10.1053/j.gastro.2021.02.036

Table 1.

Baseline Characteristics

Characteristic Data
Age, y, median (IQR)   66 (57–73)

Sex, men/women, n 400/292

ASA grade; n (%)
 I   72 (10.4)
 II 335 (48.4)
 III 269 (38.9)
 IV   16 (2.3)

Lesion size, mm, median (IQR)   40 (25–52)

Lesion site
 Esophagus, n (%) 181 (26.2)
  Distal esophagus/GEJ, n 121
  Esophageal body, n 60
 Stomach, n (%) 101 (14.6)
  Antrum, n 37
  Body, n 30
  Lesser curvature, n 14
  Fundus, n 4
  Cardia, n 16
 Duodenum, n (%)   11 (1.5)
 Colon, n (%) 399 (57.7)
  Ileocecal valve, n 11
  Cecum, n 51
  Ascending colon, n 81
  Transverse colon, n 22
  Descending colon, n 14
  Sigmoid colon, n 32
  Rectum, n 188

Polyp morphology based on Paris Classification, n (%)
 Is 132 (19.1)
 Ip   17 (2.5)
 IIa 268 (38.7)
 IIb   48 (6.9)
 IIa+IIc   66 (9.5)
 IIa+Is   32 (4.6)
 Is+IIa   24 (3.5)

Gross morphology colorectal lesions (n = 399), n (%)
 Laterally spreading tumor, granular
  Uniform   36 (9)
  Mixed 167 (41.9)
 Laterally spreading tumor, nongranular
  Flat   79 (19.8)
  Pseudodepressed   42 (10.5)

Interventions before ESD, n (%)
 None   61 (8.8)
 Tattoo underneath lesion   62 (8.9)
 Cold biopsy forceps 570 (82.4)
 Hot biopsy forceps  5 (0.72)
 Snare   51 (7.4)
 Argon plasma coagulation   23 (3.3)
 Radiofrequency ablation   46 (6.6)
 Submucosal injection only  4 (0.58)
 Endoscopic resection attempt 126 (18.2)

ASA, American Society of Anesthesiologists physical status classification; GE gastroesophageal junction.